• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL DELTEC TITANIUM PORT-A-CATH; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL DELTEC TITANIUM PORT-A-CATH; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV Back to Search Results
Model Number 21-4475-24
Device Problems Infusion or Flow Problem (2964); No Flow (2991)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/13/2022
Event Type  malfunction  
Manufacturer Narrative
A product sample was received and is awaiting evaluation, investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Event Description
It was reported that upon opening the port, it was determined it had no flow.There has been no report of patient involvement or no observable clinical symptoms or a change in symptoms identified in the patient.
 
Manufacturer Narrative
Other text: h6: health impact and evaluation codes: updated.H10: a device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.A product sample was received for evaluation.Visual and functional testing was performed.Visual inspection found a section of the catheter is attached to the port and the remaining catheter is broken in two sections.No abnormalities that could contribute to the failure mode reported are observed.Functional testing found no occlusion were identified, the pin gauge pass through the tube area without problem.Thus, failure mode is not confirmed.Device passed all functional testing.No problem found.Root cause cannot be determined as the sample was successfully tested and no discrepancies were detected.This issue will be monitored for any increase in occurrence.If the occurrence of this issue increases significantly, additional investigative action will be taken accordingly.This remediation mdr was generated under protocol (b)(4), as a result of warning letter cms# (b)(4), corrected data: d3: report source.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTEC TITANIUM PORT-A-CATH
Type of Device
PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
NULL
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
jim vegel
6000 nathan lane north
cheonho-daero
minneapolis, MN 55442
MDR Report Key15543544
MDR Text Key305891410
Report Number3012307300-2022-21282
Device Sequence Number1
Product Code LJT
UDI-Device Identifier10610586039973
UDI-Public10610586039973
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K072657
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number21-4475-24
Device Catalogue Number21-4475-24
Device Lot Number4189897
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2022
Was the Report Sent to FDA? No
Date Manufacturer Received04/02/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/10/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-